Fulcrum Therapeutics, Inc.
FULC
Revenue
0.00
0.000.00%
-Assets
260.72M
▼-18.29M▼-6.56%
3 Months ChangeLiabilities
17.68M
▼-4.03M▼-18.57%
3 Months ChangeFree Cash Flow
-25.31M
▼-1.03M▼-4.22%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-24
Form 8-K
ID: 0000950170-24-109069
2024-09-12
Form 8-K
ID: 0001193125-24-217822
2024-08-22
Form 8-K
ID: 0001193125-24-205347
2024-07-31
Form 10-Q
ID: 0000950170-24-088238
2024-07-31
Form 8-K
ID: 0000950170-24-088236
2024-06-17
Form 8-K
ID: 0001193125-24-162653
2024-05-13
Form 10-Q
ID: 0000950170-24-058193
2024-05-13
Form 8-K
ID: 0000950170-24-058187
2024-02-27
Form 8-K
ID: 0000950170-24-020615
2023-11-07
Form 10-Q
ID: 0000950170-23-059755